Animal Mammary Neoplasms

Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).
Also Known As:
Mammary Neoplasms, Animal; Animal Mammary Carcinoma; Mammary Carcinoma, Animal; Mammary Neoplasms; Neoplasms, Mammary; Animal Mammary Carcinomas; Animal Mammary Neoplasm; Carcinoma, Animal Mammary; Carcinomas, Animal Mammary; Mammary Carcinomas, Animal; Mammary Neoplasm; Mammary Neoplasm, Animal; Neoplasm, Animal Mammary; Neoplasm, Mammary; Neoplasms, Animal Mammary
Networked: 68 relevant articles (0 outcomes, 8 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Carcinoma (Carcinomatosis)
5. Infection


1. Sarli, G: 2 articles (01/2014 - 09/2006)
2. Benazzi, C: 2 articles (01/2014 - 09/2006)
3. Gärtner, F: 2 articles (01/2014 - 04/2000)
4. Roubies, N: 2 articles (09/2006 - 12/2003)
5. Koutinas, A F: 2 articles (09/2006 - 12/2003)
6. Karayannopoulou, M: 2 articles (09/2006 - 12/2003)
7. Kaldrymidou, E: 2 articles (09/2006 - 12/2003)
8. Fytianou, A: 2 articles (09/2006 - 12/2003)
9. Polizopoulou, Z S: 2 articles (09/2006 - 12/2003)
10. Ghiyasvand, Reza: 1 article (11/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Animal Mammary Neoplasms:
1. HormonesIBA
2. Peanut AgglutininIBA
3. ConnexinsIBA
4. Steroid Receptors (Steroid Receptor)IBA
5. Fibronectins (Fibronectin)IBA
6. Contraceptive Agents (Contraceptives)IBA
7. CarcinogensIBA
8. Differentiation AntigensIBA
01/01/2004 - "Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu (Erbb2), Hras, Myc, Notch4, SV40-TAg, Tgfa, and Wnt1), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV). "
01/01/2004 - "Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provides important information on the origin of neoplastic cells and their degree of differentiation. "
01/01/2004 - "On the basis of the expression of terminal differentiation markers, three types of neoplasm were identified: first, simple carcinomas composed exclusively of cells with a luminal phenotype are characteristic of neoplasms arising in mice transgenic for Neu, Hras, Myc, Notch4, and SV40-TAg; second, 'complex carcinomas' displaying luminal and myoepithelial differentiation are characteristic of type P tumors arising in mice transgenic for Wnt1, neoplasms arising in mice infected by the MMTV, and spontaneous adenosquamous carcinomas; and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras-, Myc-, and SV40-TAg-induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. "
9. tebufenozide (Mimic)IBA
10. 9,10-Dimethyl-1,2-benzanthracene (DMBA)IBA

Therapies and Procedures

1. Intraperitoneal Injections
2. Radiotherapy
3. Transplants (Transplant)
4. Drug Therapy (Chemotherapy)
5. Mediterranean Diet